No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs13005269 |
chr2:86563739-86563740 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs6760662 |
chr2:86563753-86563754 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
3 |
rs569877110 |
chr2:86563803-86563804 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs376573874 |
chr2:86563818-86563819 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs111745226 |
chr2:86563821-86563822 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs555550986 |
chr2:86563824-86563825 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs567263725 |
chr2:86563845-86563846 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs6718850 |
chr2:86563847-86563848 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
9 |
rs553369441 |
chr2:86563878-86563879 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs578176821 |
chr2:86563910-86563911 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs567218577 |
chr2:86563942-86563943 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs557091140 |
chr2:86563966-86563967 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs575435034 |
chr2:86563973-86563974 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs182201429 |
chr2:86564020-86564021 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs561086101 |
chr2:86564037-86564038 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs573137115 |
chr2:86564057-86564058 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs540648049 |
chr2:86564125-86564126 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs565155834 |
chr2:86564134-86564135 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs566231737 |
chr2:86564174-86564175 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS
|
Chromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs551706995 |
chr2:86564240-86564241 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs138233994 |
chr2:86564254-86564255 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs530769479 |
chr2:86564321-86564322 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs141214514 |
chr2:86564358-86564359 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs371434693 |
chr2:86564395-86564396 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs567383297 |
chr2:86564404-86564405 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs13024060 |
chr2:86564418-86564419 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs187407143 |
chr2:86564462-86564463 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh
|
TF binding regionCpG islandChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs145022978 |
chr2:86564490-86564491 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs571164805 |
chr2:86564513-86564514 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs538898539 |
chr2:86564543-86564544 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs557277109 |
chr2:86564548-86564549 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs190996465 |
chr2:86564569-86564570 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs536482080 |
chr2:86564583-86564584 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh
|
TF binding regionCpG islandChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs554619370 |
chr2:86564648-86564649 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription
|
TF binding regionCpG islandChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs544099237 |
chr2:86564667-86564668 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription
|
TF binding regionCpG islandChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs181020370 |
chr2:86564678-86564679 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription
|
TF binding regionCpG islandChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs545000846 |
chr2:86564806-86564807 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs113788205 |
chr2:86564815-86564816 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs573256758 |
chr2:86564819-86564820 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs540384937 |
chr2:86564833-86564834 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs565240591 |
chr2:86565004-86565005 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs577216472 |
chr2:86565007-86565008 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs138818461 |
chr2:86565024-86565025 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs563611939 |
chr2:86565047-86565048 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs185618007 |
chr2:86565130-86565131 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs370430177 |
chr2:86565141-86565142 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs190135236 |
chr2:86565244-86565245 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs560942271 |
chr2:86565292-86565293 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs182739658 |
chr2:86565300-86565301 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs187391443 |
chr2:86565302-86565303 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|